How should metabolic alkalosis be evaluated and managed?

Evaluation and Management of Metabolic Alkalosis

Metabolic alkalosis should be evaluated by measuring urinary chloride to classify the disorder as chloride-responsive (<20 mEq/L) or chloride-resistant (>20 mEq/L), which directly determines treatment strategy. 1

Initial Diagnostic Approach

Core Laboratory Assessment

• Obtain arterial blood gas showing pH >7.45, serum bicarbonate >25 mEq/L, and compensatory PCO₂ elevation to confirm metabolic alkalosis. 1
• Measure serum electrolytes including sodium, chloride (typically 85-95 mEq/L in alkalosis), potassium (often <3.5 mEq/L), and calculate the anion gap (should be normal at 8-12 mEq/L). 1
• Check urinary chloride concentration as the critical discriminating test: values <20 mEq/L indicate chloride-responsive (volume-depleted) alkalosis, while >20 mEq/L suggests chloride-resistant (renal or hormonal) causes. 1

Additional Testing for Chloride-Resistant Cases

• Measure plasma renin activity and aldosterone levels when urinary chloride is >20 mEq/L; both markedly elevated suggests secondary hyperaldosteronism from Bartter/Gitelman syndrome or ongoing diuretic use. 1
• Calculate fractional excretion of chloride (>0.5% indicates renal salt-wasting disorders like Bartter or Gitelman syndrome). 1
• Assess urinary calcium excretion to differentiate Bartter syndrome (high urinary calcium) from Gitelman syndrome (low urinary calcium/hypocalciuria). 1

Treatment Based on Etiology

Chloride-Responsive Alkalosis (Urinary Cl⁻ <20 mEq/L)

This category includes gastrointestinal losses (vomiting, nasogastric suction) and remote diuretic use.

• Administer isotonic saline (0.9% NaCl) at 15-20 ml/kg/h initially to restore extracellular volume and provide chloride, which directly corrects the alkalosis. 2, 1
• Supplement with potassium chloride 20-60 mEq/day to raise serum potassium above 3.5 mEq/L and provide additional chloride; avoid potassium citrate or potassium bicarbonate as these worsen alkalosis. 1
• Target serum potassium of 4.5-5.0 mEq/L for optimal correction, as hypokalemia perpetuates bicarbonate reabsorption. 1

Chloride-Resistant Alkalosis (Urinary Cl⁻ >20 mEq/L)

This category includes mineralocorticoid excess, ongoing diuretic therapy, and inherited tubulopathies.

• Use potassium-sparing diuretics as first-line therapy: amiloride 2.5 mg daily (titrate to 5 mg) or spironolactone 25 mg daily (titrate to 50-100 mg). 1
• Amiloride is the most effective potassium-sparing diuretic for metabolic alkalosis and provides dual benefit of correcting edema/hypertension while countering hypokalemia. 1
• Avoid combining potassium-sparing diuretics with ACE inhibitors without close monitoring due to hyperkalemia risk. 1

Diuretic-Induced Alkalosis

• Discontinue or reduce diuretic doses if clinically feasible. 1
• Switch to longer-acting loop diuretics, add a potassium-sparing diuretic (amiloride or spironolactone), or use acetazolamide for refractory cases. 1
• In heart failure patients, add an aldosterone antagonist (spironolactone) to the diuretic regimen to prevent alkalosis while managing circulatory failure. 1

Severe Metabolic Alkalosis (pH >7.55)

Severe alkalosis with pH ≥7.55 carries significantly increased mortality in critically ill patients. 3

• Administer acetazolamide 500 mg IV as a single dose when renal function is adequate (contraindicated in significant renal impairment), which causes rapid fall in serum bicarbonate with normalization of pH. 1
• Exercise caution when combining acetazolamide with other diuretics due to increased risk of dehydration and severe electrolyte imbalances. 1
• For refractory cases with concurrent renal failure, use hemodialysis with low-bicarbonate/high-chloride dialysate (25-28 mmol/L bicarbonate) as the treatment of choice. 1, 4

Special Clinical Situations

Bartter and Gitelman Syndromes

Suspect these inherited tubulopathies in euvolemic patients with hypokalemic metabolic alkalosis, hypochloremia, elevated urinary chloride (>20 mEq/L), and normal-to-low blood pressure without gastrointestinal losses or diuretic exposure. 1

Diagnostic Features

• Both plasma renin activity and aldosterone are markedly elevated (secondary hyperaldosteronism). 1
• Urinary calcium differentiates the two: high in Bartter, low in Gitelman. 1
• Fractional chloride excretion >0.5% despite volume depletion is characteristic. 1
• History of polyhydramnios and premature birth may be present, especially in severe Bartter syndrome. 1

Treatment Regimen

• Sodium chloride supplementation 5-10 mmol/kg/day to replace lost chloride. 1
• Potassium chloride (not potassium citrate or bicarbonate) to correct hypokalemia without worsening alkalosis. 1
• NSAIDs (indomethacin or ibuprofen) to inhibit prostaglandin-mediated salt wasting, particularly in symptomatic patients. 1
• Co-administer gastric acid suppression therapy (proton-pump inhibitor) when prescribing NSAIDs to prevent gastrointestinal complications. 1

Post-Hypercapnic Alkalosis

• Occurs after rapid correction of chronic hypercapnia when kidneys have retained bicarbonate to compensate for chronic respiratory acidosis. 5
• Allow gradual normalization rather than aggressive correction, as the compensatory hypoventilation (elevated PCO₂) is physiologic and maintains adequate oxygenation. 1

Iatrogenic Alkalosis

• Lactated Ringer's solution during trauma resuscitation contains lactate that is metabolized to bicarbonate once perfusion is restored. 1
• CRRT with lactate-based substitution fluid or citrate anticoagulation can introduce excess alkali in post-trauma patients. 1

Monitoring Parameters

Monitor treatment to ensure serum bicarbonate does not exceed the upper limit of normal and does not adversely affect blood pressure, serum potassium, or fluid status. 2

• Check serum electrolytes (potassium, bicarbonate, chloride) every 2-4 weeks initially, then every 3-6 months once stable. 1
• Assess volume status, blood pressure, and renal function regularly during treatment. 1
• Target serum bicarbonate within normal range (22-26 mEq/L) and serum potassium 4.5-5.0 mEq/L. 1

Critical Pitfalls to Avoid

• Never use sodium bicarbonate or alkalinization strategies in metabolic alkalosis, as these are contraindicated and worsen the disorder. 1
• Avoid potassium citrate or potassium bicarbonate for potassium repletion, as these worsen alkalosis; use potassium chloride exclusively. 1
• Do not use furosemide unless hypervolemia, hyperkalemia, or renal acidosis are present, as loop diuretics perpetuate alkalosis. 1
• Avoid potassium-sparing diuretics in patients with significant renal dysfunction or existing hyperkalemia. 1
• Do not overlook Bartter or Gitelman syndrome in euvolemic patients with unexplained hypokalemic metabolic alkalosis and elevated urinary chloride. 1